# N-acetylcysteine Protects From Aminoglycosides Induced Nephrotoxicity

> **NCT00267384** · PHASE2,PHASE3 · COMPLETED · sponsor: **Soroka University Medical Center**

## Conditions studied

- Drug Induced Nephrotoxicity

## Interventions

- **DRUG:** Oral N-Acetylcysteine

## Key facts

- **NCT ID:** NCT00267384
- **Lead sponsor:** Soroka University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2008-05
- **Final completion:** 2008-09
- **Target enrollment:** — (—)
- **Last updated:** 2012-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00267384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00267384, "N-acetylcysteine Protects From Aminoglycosides Induced Nephrotoxicity". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00267384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*